
Aurora Cannabis announced it will release its financial results for the fourth quarter and fiscal year 2026 on June 11, 2026, before market open. The company will hold a conference call at 8:00 a.m. Eastern Time to discuss the results, led by CEO Miguel Martin and CFO Simona King. This event is important for investors to assess Aurora's performance and outlook in the global medical cannabis market. Aurora operates internationally with a strong focus on quality and patient care.